Abstract
Objectives
Hand dysfunction causes significant reduction in quality of life in systemic sclerosis. We assessed the validity and reliability of the culturally adapted Indian version of Cochin Hand Function Scale (I-CHFS). We determined the factors contributing to hand dysfunction and its burden on quality of life.
Method
I-CHFS was formulated by replacing five questions (questions 7, 9, 10, 14 and 15) in CHFS which were determined as unsuitable in an Indian setting. The instrument was assessed for acceptability, reliability, reproducibility and validity measures. A total of 87 patients were assessed for various demographic and disease parameters, hand disability and quality of life.
Results
The median I-CHFS score was 22(5–54) and 04 (0.5–17.5) among diffuse (dcSSc) and limited cutaneous systemic sclerosis (lcSSc). I-CHFS showed good reproducibility (interclass correlation coefficient = 0.92) and a strong correlation with I-HAQ (rs = 0.832), usual activities EQ-5D-5L (rs = 0.744), self-care EQ-5D-5L (rs = 0.734) and anxiety/depression EQ-5D-5L (rs = 0.729). It had moderate correlation with pain/discomfort EQ-5D-5L (rs = 0.661) and hand HAQ (rs = 0.576) and poor correlation with HAQ-DI (rs = 0.396) and modified Rodnan skin score (rs = 0.390). Finger to table distance, finger to palm distance in extension and limited hand modified Rodnan skin score were significantly associated with higher values of I-CHFS.
Conclusions
Hand dysfunction in systemic sclerosis is substantial and contributes significantly to poor quality of life. The culturally adapted I-CHFS is a valid and reliable tool to assess it and correlated well with the overall disease burden.
Key Points • Hand dysfunction is common among systemic sclerosis patients. • Hand dysfunction contributes to the poor quality of life and more disease burden. • Culturally adapted Cochin Hand function Scale helps assess hand dysfunction among Indian scleroderma patients. |
Similar content being viewed by others
References
LeRoy EC, Black C, Fleischmajer R et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205
Kucharz EJ, Kopeć-Mędrek M (2017) Systemic sclerosis sine scleroderma. Adv Clin Exp Med 26:875–880. https://doi.org/10.17219/acem/64334
Young A, Namas R, Dodge C, Khanna D (2016) Hand impairment in systemic sclerosis: various manifestations and currently available treatment. Curr Treatm Opt Rheumatol 2:252–269. https://doi.org/10.1007/s40674-016-0052-9
Sandqvist G, Eklund M (2000) Hand mobility in scleroderma (HAMIS) test: the reliability of a novel hand function test. Arthritis Care Res 13:369–374. https://doi.org/10.1002/1529-0131(200012)13:6<369::AID-ART6>3.0.CO;2-X
Backman C, Mackie H, Harris J (1991) Arthritis hand function test: development of a standardized assessment tool. Occup Ther J Res 11:245–256. https://doi.org/10.1177/153944929101100405
Duruöz MT, Poiraudeau S, Fermanian J, Menkes CJ, Amor B, Dougados M, Revel M (1996) Development and validation of a rheumatoid hand functional disability scale that assesses functional handicap. J Rheumatol 23:1167–1172
Brower LM, Poole JL (2004) Reliability and validity of the Duruoz hand index in persons with systemic sclerosis (scleroderma). Arthritis Rheum 51:805–809. https://doi.org/10.1002/art.20701
Fries JF, Spitz P, Kraines RG, Holman HR (1980) Measurement of patient outcome in arthritis. Arthritis Rheum 23:137–145. https://doi.org/10.1002/art.1780230202
Pope J (2011) Measures of systemic sclerosis (scleroderma): Health Assessment Questionnaire (HAQ) and Scleroderma HAQ (SHAQ), physician- and patient-rated global assessments, Symptom Burden Index (SBI), University of California, Los Angeles, Scleroderma Clinical Trials Consortium Gastrointestinal Scale (UCLA SCTC GIT) 2.0, Baseline Dyspnea Index (BDI) and Transition Dyspnea Index (TDI) (Mahler’s Index), Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR), and Raynaud’s Condition Score (RCS). Arthritis Care Res 63(Suppl 11):S98–S111. https://doi.org/10.1002/acr.20598
Steen VD, Medsger TA (1997) The value of the health assessment questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum 40:1984–1991. https://doi.org/10.1002/art.1780401110
Balestroni G, Bertolotti G (2012) EuroQol-5D (EQ-5D): an instrument for measuring quality of life. Monaldi Arch Chest Dis 78:155–159. https://doi.org/10.4081/monaldi.2012.121
Kumar A, Malaviya AN, Pandhi A, Singh R (2002) Validation of an Indian version of the health assessment questionnaire in patients with rheumatoid arthritis. Rheumatology 41:1457–1459. https://doi.org/10.1093/rheumatology/41.12.1457
Hanel PHP, Maio GR, Soares AKS, Vione KC, de Holanda Coelho GL, Gouveia VV, Patil AC, Kamble SV, Manstead ASR (2018) Cross-cultural differences and similarities in human value instantiation. Front Psychol 9:849. https://doi.org/10.3389/fpsyg.2018.00849
Bansal P, Vineyard E, Abdelaziz O (2011) Advances in household appliances- a review. Appl Therm Eng 31:3748–3760. https://doi.org/10.1016/j.applthermaleng.2011.07.023
van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA Jr, Carreira PE, Riemekasten G, Clements PJ, Denton CP, Distler O, Allanore Y, Furst DE, Gabrielli A, Mayes MD, van Laar JM, Seibold JR, Czirjak L, Steen VD, Inanc M, Kowal-Bielecka O, Müller-Ladner U, Valentini G, Veale DJ, Vonk MC, Walker UA, Chung L, Collier DH, Csuka ME, Fessler BJ, Guiducci S, Herrick A, Hsu VM, Jimenez S, Kahaleh B, Merkel PA, Sierakowski S, Silver RM, Simms RW, Varga J, Pope JE (2013) Classification criteria for systemic sclerosis: an ACR-EULAR collaborative initiative. Arthritis Rheum 65:2737–2747. https://doi.org/10.1002/art.38098
Acquadro C, Conway K, Hareendran A, Aaronson N, European Regulatory Issues and Quality of Life Assessment (ERIQA) Group (2008) Literature review of methods to translate health-related quality of life questionnaires for use in multinational clinical trials. Value Health 11:509–521. https://doi.org/10.1111/j.1524-4733.2007.00292.x
Guillemin F, Bombardier C, Beaton D (1993) Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol 46:1417–1432. https://doi.org/10.1016/0895-4356(93)90142-n
Clements PJ (1995) Measuring disease activity and severity in scleroderma. Curr Opin Rheumatol 7:517–521
Torok KS, Baker NA, Lucas M, Domsic RT, Boudreau R, Medsger TA Jr (2010) Reliability and validity of the delta finger-to-palm (FTP), a new measure of finger range of motion in systemic sclerosis. Clin Exp Rheumatol 28:S28–S36
Johnsson PM, Eberhardt K (2009) Hand deformities are important signs of disease severity in patients with early rheumatoid arthritis. Rheumatology (Oxford) 48:1398–1401. https://doi.org/10.1093/rheumatology/kep253
Tavakol M, Dennick R (2011) Making sense of Cronbach’s alpha. Int J Med Educ 2:53–55. https://doi.org/10.5116/ijme.4dfb.8dfd
Koo TK, Li MY (2016) A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med 15:155–163. https://doi.org/10.1016/j.jcm.2016.02.012
Akoglu H (2018) User’s guide to correlation coefficients. Turk J Emerg Med 18:91–93. https://doi.org/10.1016/j.tjem.2018.08.001
Hesselstrand R, Nilsson J-Å, Sandqvist G (2013) Psychometric properties of the Swedish version of the scleroderma health assessment questionnaire and the Cochin hand function scale in patients with systemic sclerosis. Scand J Rheumatol 42:317–324. https://doi.org/10.3109/03009742.2012.756928
Kwakkenbos L, Sanchez TA, Turner KA et al (2018) The association of sociodemographic and disease variables with hand function: a scleroderma patient-centered intervention network cohort study. Clin Exp Rheumatol 36(Suppl 113):88–94
Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL (2006) Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367:1747–1757. https://doi.org/10.1016/S0140-6736(06)68770-9
Tyndall AJ, Bannert B, Vonk M, Airo P, Cozzi F, Carreira PE, Bancel DF, Allanore Y, Muller-Ladner U, Distler O, Iannone F, Pellerito R, Pileckyte M, Miniati I, Ananieva L, Gurman AB, Damjanov N, Mueller A, Valentini G, Riemekasten G, Tikly M, Hummers L, Henriques MJ, Caramaschi P, Scheja A, Rozman B, Ton E, Kumanovics G, Coleiro B, Feierl E, Szucs G, von Muhlen CA, Riccieri V, Novak S, Chizzolini C, Kotulska A, Denton C, Coelho PC, Kotter I, Simsek I, de la Pena Lefebvre PG, Hachulla E, Seibold JR, Rednic S, Stork J, Morovic-Vergles J, Walker UA (2010) Causes and risk factors for death in systemic sclerosis: a study from the EULAR scleroderma trials and research (EUSTAR) database. Ann Rheum Dis 69:1809–1815. https://doi.org/10.1136/ard.2009.114264
Herdman M, Gudex C, Lloyd A, Janssen MF, Kind P, Parkin D, Bonsel G, Badia X (2011) Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 20:1727–1736. https://doi.org/10.1007/s11136-011-9903-x
Georges C, Chassany O, Mouthon L, Tiev K, Toledano C, Meyer O, Marjanovic Z, Heneggar C, Papo T, Crickx B, Sereni D, Cabane J, Farge D (2005) Validation of French version of the scleroderma health assessment questionnaire (SSc HAQ). Clin Rheumatol 24:3–10. https://doi.org/10.1007/s10067-004-0942-3
Rannou F, Poiraudeau S, Berezné A, Baubet T, le-guern V, Cabane J, Guillevin L, Revel M, Fermanian J, Mouthon L (2007) Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin hand function scale, health assessment questionnaire (HAQ), systemic sclerosis HAQ, and medical outcomes study 36-item short form health survey. Arthritis Rheum 57:94–102. https://doi.org/10.1002/art.22468
Dougherty DH, Kwakkenbos L, Carrier M-E, Salazar G, Assassi S, Baron M, Bartlett SJ, Furst DE, Gottesman K, van den Hoogen F, Malcarne VL, Mouthon L, Nielson WR, Poiraudeau S, Sauvé M, Boire G, Bruns A, Chung L, Denton C, Dunne JV, Fortin P, Frech T, Gill A, Gordon J, Herrick AL, Hinchcliff M, Hudson M, Johnson SR, Jones N, Kafaja S, Larché M, Manning J, Pope J, Spiera R, Steen V, Sutton E, Thorne C, Wilcox P, Thombs BD, Mayes MD, SPIN Investigators, Albert A, Arsenault G, Bissonette L, Boutron I, Carreira P, Maia AC, Dagenais P, Domsic R, el-Baalbaki G, Ells C, van den Ende C, Fligelstone K, Fortune C, Godard D, Gyger G, Harel D, Ikic A, Impens A, Jang Y, Artur Jose de BF, Kennedy AT, Khalidi N, Korman B, Leite C, Liang P, Marra C, Masetto A, Nielsen K, Portales A, Riggs R, Reyna TSR, Roux S, Schouffoer AA, Steele RJ, Suarez-Almazor ME, Varga J, Welling J, Wigley F, Wong-Rieger D, Cumin J, Delisle VC, Fedoruk C, Fox RS, Gholizadeh S, Jewett LR, Levis B, Mills SD, Pepin MR, Persmann J, Turner K (2018) The scleroderma patient-centered intervention network cohort: baseline clinical features and comparison with other large scleroderma cohorts. Rheumatology 57:1623–1631. https://doi.org/10.1093/rheumatology/key139
Pokeerbux MR, Giovannelli J, Dauchet L, Mouthon L, Agard C, Lega JC, Allanore Y, Jego P, Bienvenu B, Berthier S, Mekinian A, Hachulla E, Launay D (2019) Survival and prognosis factors in systemic sclerosis: data of a French multicenter cohort, systematic review, and meta-analysis of the literature. Arthritis Res Ther 21:86. https://doi.org/10.1186/s13075-019-1867-1
Clements PJ, Furst DE, Wong WK, Mayes M, White B, Wigley F, Weisman MH, Barr W, Moreland LW, Medsger Jr TA, Steen V, Martin RW, Collier D, Weinstein A, Lally E, Varga J, Weiner S, Andrews B, Abeles M, Seibold JR (1999) High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial. Arthritis Rheum 42:1194–1203. https://doi.org/10.1002/1529-0131(199906)42:6<1194::AID-ANR16>3.0.CO;2-7
Furst DE, Clements PJ, Harris R, Ross M, Levy J, Paulus HE (1979) Measurement of clinical change in progressive systemic sclerosis: a 1 year double-blind placebo-controlled trial of N-acetylcysteine. Ann Rheum Dis 38:356–361
Skare TL, Toebe BL, Boros C (2011) Hand dysfunction in scleroderma patients. Sao Paulo Med J 129:357–360. https://doi.org/10.1590/s1516-31802011000500012
Streiner DL (2003) Starting at the beginning: an introduction to coefficient alpha and internal consistency. J Pers Assess 80:99–103. https://doi.org/10.1207/S15327752JPA8001_18
Gheorghiu AM, Gyorfi H, Capotă R, Matei A, Oneaţă R, Bojincă M, Stoica V, Mihai C (2019) Reliability, validity, and sensitivity to change of the Cochin hand functional disability scale and testing the new 6-item Cochin hand functional disability scale in systemic sclerosis. J Clin Rheumatol Publish Ahead of Print. https://doi.org/10.1097/RHU.0000000000001195
Acknowledgements
Mrs. Kalaichelvi K. and Miss Priyanka B. helped in Tamil translation of the questionnaire. Miss Rubini V. the speciality nurse helped in patient recruitment and the data collection and telephonic follow-up.
Author information
Authors and Affiliations
Contributions
DB: Design of the study, acquisition and interpretation of data and drafting the work
CGK: Design of the study, acquisition, interpretation of data and drafting the work
AMB: Acquisition, interpretation of data and drafting the work
AG: Tamil translation of the questionnaire and data acquisition
VSN: Conception and design of study, interpretation of data and drafting the work
All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Disclosures
None.
Code availability
Not applicable
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Bairwa, D., Kavadichanda, C.G., Adarsh, M.B. et al. Cultural adaptation, translation and validation of Cochin Hand Function Scale and evaluation of hand dysfunction in systemic sclerosis. Clin Rheumatol 40, 1913–1922 (2021). https://doi.org/10.1007/s10067-020-05434-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-020-05434-4